A new study by a professor of the faculty of medicine at Université Laval suggests that the use of nanoparticles made out of gold could improve the effectiveness of eye disease treatments.

Professor Élodie Boisselier holds a patent for a technology that allows an ophthalmic drug to adhere to the mucous membrane of the eye thanks to the use of gold nanoparticles. This type of technology can improve the life of patients with cataracts, and with its post-surgical treatment.

Learn more about this new technology: https://bit.ly/3oHC1Gt